Professor Zhao Xinkai, Director of the Endoscopy Center, said that so far, the system has found 3 cases of early gastrointestinal malignancies that are easily missed or misdiagnosed by the naked eye.
The “Third Eye” of endoscopists
Mr. Chen is 43 years old, and he has no bad living habits and no physical discomfort. Six days ago, when he performed a routine physical examination at the Health Management Center of Hainan Chengmei Hospital and did a gastroenteroscopy, the ENDOANGEL beside him snapped an alarm.
The examining physician collected the test specimen according to the systems guidelines. The 20-day pathological examination results were "high-grade intraepithelial neoplasia (stomach) with local adenocarcinoma cells". Professor Zhao Xinkai introduced that because the discovery was very early, the cancer cells were still confined to the mucosal layer, did not invade other tissues, and did not spread.
Mr. Chen attaches great importance to the health management of himself and his family, and has regular physical examinations every year. Upon learning of the diagnosis, Chen quipped: "Its even luckier than winning the jackpot!”
ENDOANGEL® is an artificial intelligence digestive endoscopy assisted diagnosis and treatment system based on deep learning technology, which is known as the "third eye" of endoscopists. It can monitor gastrointestinal endoscopic images in real time and intelligently indicate suspicious lesions, especially detect and screen microscopic or very early mucosal carcinomas that are not visible to the naked eye, effectively reducing the occurrence of missed diagnosis and misdiagnosis, and improving the detection rate of early cancers.
The system was introduced to Hainan for the first time. Zhao Xinkai introduced that in the more than a month since the arrival of ENDOANGEL, it has demonstrated its "divine power" and has "pulled out" many cases of early esophageal and gastric cancer, among which 3 cases are early malignant tumors of the digestive tract that cannot be found by conventional endoscopy.
Early diagnosis and treatment of gastrointestinal tumors
Patients benefit more
Patients with gastrointestinal malignancies account for nearly half of all new onset and death of cancer. The latest national cancer report released by the National Cancer Center shows that malignant tumors of digestive tract show a high incidence and trend of younger, and the prevention and treatment situation is very serious.
However, malignant tumors of digestive tract can be prevented and controlled. Professor Zhao Xinkai has been engaged in the prevention and treatment of digestive diseases for more than 30 years, and is a well-known endoscope and digestive tract expert in Hainan. He introduced that 80% of gastrointestinal malignancies are caused by gastrointestinal benign polyps, ulcers and other lesions, that is to say, 80% of gastrointestinal malignancies are preventable and controllable.
Zhao Xinkai said that if the early gastrointestinal cancer was treated earlier, patients will benefit more. First, the trauma is small. Generally, the tumor can be exfoliated under endoscopy without affecting the normal life of patients. Second, the harm is low. All tumors are the same, the earlier the detection, the smaller the risk of metastasis, spread, and it can even be treated reaching the standard of cure; Third, the cost is low. The treatment cost of middle and advanced malignant tumors is more than 10 times higher than that of early malignant tumors. The fourth is to survive long. The 5-year survival rate of early gastrointestinal tumors is more than 90%, while the 5-year survival rate of advanced patients is only about 10%, and their life quality is very poor.
"Gastrointestinal tumors are the same as other malignant tumors, the most effective way to prevent and control them is early detection, early diagnosis and early treatment .” Zhao Xinkai pointed out that at present, the most effective and reliable screening method for early gastrointestinal cancer is electronic gastroenteroscopy. However, during conventional endoscopy, the detection of early lesions mainly depends on the endoscopists personal experience and level, especially for tiny lesions, which are generally difficult to detect with the naked eye, and even the most experienced physicians will be unable to do anything about it, while ENDOANGEL exactly makes up for these defects and can detect tumor traces earlier to benefit and save more patients.
Zhao Xinkai said that the assistance of AI technology effectively reduces the dependence of endoscopy on expert experience, improves the quality of endoscopy, and can find earlier lesions, so that patients can benefit more.
All three patients, including Mr. Chen, required only minimally invasive local treatment because of early detection, and did not require any other treatment, which would do little or no impact on their health and life.
Next and pictures from Liang Shan